Tiotropium Bromide Capsule
Product Images NDC 68180-964

Product Visual Gallery

This gallery contains 26 technical images submitted to the FDA as part of the official labeling for Tiotropium Bromide (NDC 68180-964). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (020f2aee 11dd 4990 Bed2 Df9ea1ce877b 01)

Chemical structure of Tiotropium Bromide, showing its molecular arrangement including the bicyclic ring system, thiophene groups, and bromide with water of hydration (H2O).*

FDA Label Image

Image (020f2aee 11dd 4990 Bed2 Df9ea1ce877b 02)

Two line graphs comparing FEV1 (forced expiratory volume in 1 second in liters) over 12 hours between Tiotropium (n=202) and placebo (n=179) groups on Day 1 and Day 169. The Tiotropium group shows higher FEV1 values throughout the time period compared to placebo.*

FDA Label Image

Image (020f2aee 11dd 4990 Bed2 Df9ea1ce877b 03)

Two line graphs comparing FEV1 (L) over time (hours) for Tiotropium and Ipratropium treatments on Day 1 and Day 92. The graphs show FEV1 values on the y-axis and time from 0 to 6 hours on the x-axis, illustrating changes in lung function after dosing for groups of 153 and 72 subjects respectively.*

FDA Label Image

Image (020f2aee 11dd 4990 Bed2 Df9ea1ce877b 04)

Line chart comparing FEV1 (L) over 48 months between Tiotropium and Control groups. The chart shows FEV1 on the vertical axis (1.00 to 1.30 L) and time in months on the horizontal axis, with measurements starting at day 30 (steady state) through 48 months. Tiotropium group data is marked with triangles, control with squares, depicting higher FEV1 sustained in the Tiotropium group throughout the period.*

FDA Label Image

Image (020f2aee 11dd 4990 Bed2 Df9ea1ce877b 05)

An instructional illustration showing a person's profile with an open mouth and a hand holding a capsule, with a diagonal line crossing between them, indicating that the capsule should not be taken orally by mouth. This likely relates to Tiotropium Bromide capsules intended for inhalation, not swallowing.*

FDA Label Image

Image (020f2aee 11dd 4990 Bed2 Df9ea1ce877b 06)

An instructional illustration showing a person about to orally ingest a capsule, with a prohibition symbol (circle with a diagonal line) indicating that the capsule should not be swallowed directly. The image suggests the capsule is not meant to be taken by mouth in this manner.*

FDA Label Image

Image (020f2aee 11dd 4990 Bed2 Df9ea1ce877b 07)

Instructional diagram labeled Figure A showing a hand holding and opening a tiotropium bromide inhaler device. The diagram includes numbered callouts on various parts of the inhaler, illustrating the opening mechanism and important device components for use.*

FDA Label Image

Image (020f2aee 11dd 4990 Bed2 Df9ea1ce877b 08)

An instructional diagram showing hands holding and separating individual foil pouches containing Tiotropium Bromide inhalation capsules. Each pouch is labeled with product information including strength 18 mcg, intended for oral and respiratory inhalation use.*

FDA Label Image

Image (020f2aee 11dd 4990 Bed2 Df9ea1ce877b 09)

An illustration depicting a Tiotropium Bromide capsule labeled with "LU" on the top half and "T18" on the bottom half. An arrow points to the capsule with text indicating the amount of powder contained in the Tiotropium Bromide inhalation powder capsule.*

FDA Label Image

Image (020f2aee 11dd 4990 Bed2 Df9ea1ce877b 10)

An instructional illustration labeled Figure D showing a hand holding and pressing a component of an inhalation device, with an arrow indicating the direction for sliding or pressing a part of the device, likely related to the use of an inhalation capsule product.*

FDA Label Image

Image (020f2aee 11dd 4990 Bed2 Df9ea1ce877b 11)

An instructional diagram showing a hand holding a tiotropium bromide inhaler device. Two black arrows indicate the motion of pressing and releasing the top part of the inhaler, illustrating how to operate the device for capsule inhalation.*

FDA Label Image

Image (020f2aee 11dd 4990 Bed2 Df9ea1ce877b 12)

An illustration showing a hand operating a device by lifting a cover or part upwards, indicating a step in using an inhalation device for Tiotropium Bromide capsules. The diagram highlights manual interaction with the inhaler mechanism, likely part of patient usage instructions.*

FDA Label Image

Image (020f2aee 11dd 4990 Bed2 Df9ea1ce877b 13)

Illustration showing hands removing a single capsule from a blister packaging strip. The image is likely instructional, demonstrating how to separate and extract an individual capsule from the strip containing multiple capsules, relevant to Tiotropium Bromide capsules.*

FDA Label Image

Image (020f2aee 11dd 4990 Bed2 Df9ea1ce877b 14)

An instructional illustration showing hands peeling back a label or sticker from a surface. The image includes magnified insets highlighting the label details and a bold text label "PEEL BACK" to indicate the peeling action.*

FDA Label Image

Image (020f2aee 11dd 4990 Bed2 Df9ea1ce877b 15)

An instructional diagram showing a hand holding a capsule labeled '18' above an inhaler device, with an arrow indicating insertion of the capsule into the inhaler. The illustration demonstrates how to place the Tiotropium Bromide 18 mcg capsule into the inhaler for oral respiratory inhalation.*

FDA Label Image

Image (020f2aee 11dd 4990 Bed2 Df9ea1ce877b 16)

An instructional illustration showing a hand pressing down on the top of a handheld inhaler device with a cap flipped open, demonstrating the method to actuate or prepare the inhaler for use.*

FDA Label Image

Image (020f2aee 11dd 4990 Bed2 Df9ea1ce877b 17)

An instructional diagram showing a hand holding a Tiotropium Bromide inhalation device with the mouthpiece cover open. An arrow indicates the direction to slide a part of the device, illustrating how to prepare it for use.*

FDA Label Image

Image (020f2aee 11dd 4990 Bed2 Df9ea1ce877b 18)

An instructional illustration showing a side profile of a person's mouth exhaling a visible cloud of mist, indicated by an arrow pointing outward. This image likely demonstrates proper inhalation or exhalation technique related to the use of Tiotropium Bromide inhalation capsules.*

FDA Label Image

Image (020f2aee 11dd 4990 Bed2 Df9ea1ce877b 19)

An instructional illustration showing a person holding a capsule inhaler near their mouth, positioned to inhale the medication. The image depicts correct usage technique for an oral respiratory inhalation capsule.*

FDA Label Image

Image (020f2aee 11dd 4990 Bed2 Df9ea1ce877b 20)

An illustration showing a side profile of a person exhaling, with an arrow indicating the direction of the breath outward from the mouth. This likely demonstrates the proper use of an inhalation device for dispensing Tiotropium Bromide capsules.*

FDA Label Image

Image (020f2aee 11dd 4990 Bed2 Df9ea1ce877b 21)

An instructional diagram showing a hand holding an inhaler device near a person's mouth, with an arrow indicating the direction to inhale from the device. This likely illustrates how to use the Tiotropium Bromide inhalation capsule.*

FDA Label Image

Image (020f2aee 11dd 4990 Bed2 Df9ea1ce877b 22)

An instructional diagram showing a hand operating a Tiotropium Bromide inhaler device. The illustration highlights correct finger placement and pressing motion on the inhaler mechanism, with directional arrows indicating the intended motion.*

FDA Label Image

Image (020f2aee 11dd 4990 Bed2 Df9ea1ce877b 23)

Illustration showing a hand holding a device with a central clip or slot, positioned above a surface with arrows indicating movement directions, possibly demonstrating how to attach or insert the device.*

FDA Label Image

Image (020f2aee 11dd 4990 Bed2 Df9ea1ce877b 24)

An instructional diagram showing a hand cleaning the inside of a device with a cotton swab under running water. The device appears to be a component related to the Tiotropium Bromide inhalation capsules, demonstrating maintenance or cleaning steps.*

FDA Label Image

Blister Label (020f2aee 11dd 4990 Bed2 Df9ea1ce877b 25)

Multiple identical blister pack labels for Tiotropium Bromide Inhalation Powder 18 micrograms per capsule, intended for oral inhalation. The label includes product name, dosage strength, instructions to use only as inhalation capsules, barcodes, manufacturing details by Lupin Pharmaceuticals, Inc., and peel-back tabs. The packaging is arranged to accommodate a multi-dose inhaler system.*

FDA Label Image

Carton Pack 30s (020f2aee 11dd 4990 Bed2 Df9ea1ce877b 26)

Packaging label for Tiotropium Bromide Inhalation Powder 18 mcg per capsule by Lupin Pharmaceuticals, Inc. The label indicates this is a capsule dosage form intended for oral/respiratory inhalation. The package contains 30 capsules, arranged as 3 blister cards with 10 capsules each. The label notes that the package is not child resistant and includes usage warnings.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.